The Importance of Mg 2+ ‐Free State in Nucleotide Exchange of Oncogenic K‐Ras Mutants
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
The Importance of Mg 2+ ‐Free State in Nucleotide Exchange of Oncogenic K‐Ras Mutants ; day:01 ; month:09 ; year:2022 ; extent:1
Chemistry - a European journal ; (01.09.2022) (gesamt 1)
- Urheber
-
Pálfy, Gyula
Menyhárd, Dóra K.
Ákontz‐Kiss, Hanna
Vida, István
Batta, Gyula
Tőke, Orsolya
Perczel, András
- DOI
-
10.1002/chem.202201449
- URN
-
urn:nbn:de:101:1-2022090115254274721939
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:33 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Pálfy, Gyula
- Menyhárd, Dóra K.
- Ákontz‐Kiss, Hanna
- Vida, István
- Batta, Gyula
- Tőke, Orsolya
- Perczel, András
Ähnliche Objekte (12)
Oncogenic KRAS supports pancreatic cancer through regulation of nucleotide synthesis
Oncogenic KRAS supports pancreatic cancer through regulation of nucleotide synthesis
Excited-state observation of active K-Ras reveals differential structural dynamics of wild-type versus oncogenic G12D and G12C mutants
The relationship between oncogenic KRas and wild-type Ras activity and signaling
A novel protein RASON encoded by a lncRNA controls oncogenic RAS signaling in KRAS mutant cancers
Immune modulatory effects of oncogenic KRAS in cancer
Oncogenic KRAS promotes malignant brain tumors in zebrafish
K-Ras protein as a drug target
Unraveling (K)RAS in pancreatic ductal adenocarcinoma
Graded inhibition of oncogenic Ras-signaling by multivalent Ras-binding domains
Oncogenic KrasG12D causes myeloproliferation via NLRP3 inflammasome activation
Oncogenic KRAS blockade therapy: renewed enthusiasm and persistent challenges
Oncogenic KRAS supports pancreatic cancer through regulation of nucleotide synthesis
Oncogenic KRAS supports pancreatic cancer through regulation of nucleotide synthesis
Excited-state observation of active K-Ras reveals differential structural dynamics of wild-type versus oncogenic G12D and G12C mutants
The relationship between oncogenic KRas and wild-type Ras activity and signaling
A novel protein RASON encoded by a lncRNA controls oncogenic RAS signaling in KRAS mutant cancers
Immune modulatory effects of oncogenic KRAS in cancer
Oncogenic KRAS promotes malignant brain tumors in zebrafish
K-Ras protein as a drug target
Unraveling (K)RAS in pancreatic ductal adenocarcinoma
Graded inhibition of oncogenic Ras-signaling by multivalent Ras-binding domains
Oncogenic KrasG12D causes myeloproliferation via NLRP3 inflammasome activation
Oncogenic KRAS blockade therapy: renewed enthusiasm and persistent challenges
Oncogenic KRAS supports pancreatic cancer through regulation of nucleotide synthesis
Oncogenic KRAS supports pancreatic cancer through regulation of nucleotide synthesis
Excited-state observation of active K-Ras reveals differential structural dynamics of wild-type versus oncogenic G12D and G12C mutants
The relationship between oncogenic KRas and wild-type Ras activity and signaling
A novel protein RASON encoded by a lncRNA controls oncogenic RAS signaling in KRAS mutant cancers
Immune modulatory effects of oncogenic KRAS in cancer
Oncogenic KRAS promotes malignant brain tumors in zebrafish
K-Ras protein as a drug target
Unraveling (K)RAS in pancreatic ductal adenocarcinoma
Graded inhibition of oncogenic Ras-signaling by multivalent Ras-binding domains
Oncogenic KrasG12D causes myeloproliferation via NLRP3 inflammasome activation